< Back to the Blog

About the author

Ioana Calcev
Ioana Calcev is Chief Operating Officer at Oova. She's dedicated to empowering women with the data and insights they need to understand their hormone health and advocate for better care.

Sources

  • Stuenkel CA, et al. "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism. 2015;100(11):3975–4011.
  • Stanczyk FZ, et al. "Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception." Reviews in Endocrine and Metabolic Disorders. 2002;3(3):211–224.
  • Kuhl H. "Pharmacology of estrogens and progestogens: influence of different routes of administration." Climacteric. 2005;8(Suppl 1):3–63.
  • Röst A, et al. "Variability of transdermal estrogen delivery and its clinical implications." Maturitas. 2019;124:1–6.
  • Prior JC. "Progesterone for Symptomatic Perimenopause Treatment." Facts Views Vis Obgyn. 2011;3(2):109–120.
  • Pinkerton JV, et al. "The Menopause Society 2023 hormone therapy position statement." Menopause. 2023;30(4):321–326.
  • Glaser R, Dimitrakakis C. "Testosterone therapy in women: myths and misconceptions." Maturitas. 2013;74(3):230–234.

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.